Giant Cell Tumor — Trials

Giant Cell Tumor — Trials · CancerIndex

Clinical trials

Registered studies

52 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04938180	A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients	terminated	Phase 2	4	AmMax Bio, Inc.INDUSTRY	3	May 24, 2024	clinicaltrials
NCT03620149	Reduced Dose-density of Denosumab for Unresectable GCTB(REDUCE)	terminated	Phase 2	2	European Organisation for Research and Treatment of Cancer - EORTCNETWORK	4	Jan 6, 2021	clinicaltrials
NCT01804530	Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors	terminated	Phase 1	59	PlexxikonINDUSTRY	1	Aug 2, 2018	clinicaltrials
NCT02673736	A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor

Data updated 22 days agoSource updated May 24, 2024source: clinicaltrials